The present invention relates to a biodegradable plastic made from a combination of at least one synthetic plastic polymer, at least one natural polymer and a natural polymer attacking agent and articles made therefrom. The present invention further relates to a method of eliminating hydrocarbon contaminating a region subjected to extreme temperatures by contacting the region with hydrocarbon-degrading microorganisms and adjusting the temperature of the region for optimum growth. The present inv...

Compositions are provided for the preparation of stable sodium aspirin tablets. The compositions comprise dry, crystalline sodium aspirin, an anhydrous binder that is unreactive to sodium aspirin and a hydrogenated animal or vegetable oil lubricant but lack the traditional tablet disintegrant. Tablets produced from these compositions can be stored for prolonged periods of time yet disintegrate in water at a rate comparable to that of ordinary aspirin.

The invention provides the use of a cyclooxygenase inhibitor such as the non-steroidal anti-inflammatory agent aspirin in the manufacture of a medicament to enhance perfusion of blood through the mammalian, preferably human, uterus. The enhanced perfusion aids embryo implantation in natural or assisted methods of conception.

Gelatin coated pharmaceutical dosage units containing, for example, analgesic compounds, such as aspirin, stabilized with a proteolytic enzyme, such as pepsin, are described.

The present invention concerns a novel medicament based on aspirin and heptaminol (that is to say, 6-amino-2-methyl-2-heptanol).

A novel coprecipitate of aspirin and tea is described. The coprecipitate is prepared by acidification of a solution of aspirin and tea. In vivo pharmacological evaluation of the coprecipitate shows that the therapeutic activity of aspirin has been retained and the side effects commonly associated with aspirin such as irritation of the gastric mucosa, bleeding and ulceration have been markedly reduced.

An analgesic aspirin composition in dosage form having acetylsalicylic acid and unreacted glycine in an amount equal to at least approximately 33.3% of the weight of the acetylsalicylic acid for rendering the aspirin nontoxic upon swallowing the aspirin composition, as well as rendering the aspirin sublingually absorbable.

A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing the therapeutic methods of the invention are also disclosed.

The invention describes a method for the synthesis of nitroxymethylphenyl esters of aspirin derivatives.

An analgesic cosmetic formulation in the form of an ointment, salve or cream which is applied to the skin, including the hands and feet for the treatment of such conditions as redness, swelling, itching and soreness of the skin. The cosmetic formulation contains ingredients including oranges, avocado, watermelon, banana, lemon, palm oil, coconut oil, petroleum jelly, beeswax, aloe vera, vitamin E, aspirin, ammonium sulfate, sodium bisulfate and quine sulfate.